SeaStar Medical Holding (ICU) Current Assets (2020 - 2026)
SeaStar Medical Holding's (ICU) quarterly Current Assets came in at $10.8 million in Q1 2026, up 58.67% YoY from $6.8 million in Q1 2025, and down 20.74% on a QoQ basis from $13.6 million in Q4 2025.
SeaStar Medical Holding (ICU) Current Assets (2020 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 7 years of Current Assets data on file, last reported at $10.8 million in Q1 2026.
- Quarterly Current Assets rose 58.67% year-over-year to $10.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.8 million (up 58.67% YoY) and the FY2025 annual result came in at $13.6 million, up 260.59% from the prior year.
- Current Assets declined to $10.8 million in Q1 2026, from $13.6 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $107.3 million in Q3 2022 to a low of $1.2 million in Q3 2023.
- A 5-year average of $23.4 million and a median of $6.5 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets jumped 17077.73% — and 2023, when it sank 98.86%.
- Tracing ICU's Current Assets over 5 years: stood at $1.5 million in 2022, then soared by 51.94% to $2.3 million in 2023, then soared by 63.17% to $3.8 million in 2024, then surged by 260.59% to $13.6 million in 2025, then slipped by 20.74% to $10.8 million in 2026.
- The last three Current Assets figures came in at $10.8 million (Q1 2026), $13.6 million (Q4 2025), and $14.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | 8.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.23 Mn |
| Mar 31, 2026 | 10.76 Mn |
| Dec 31, 2025 | 13.58 Mn |
| Sep 30, 2025 | 14.87 Mn |
| Jun 30, 2025 | 7.65 Mn |
| Mar 31, 2025 | 6.78 Mn |
| Dec 31, 2024 | 3.77 Mn |
| Sep 30, 2024 | 3.62 Mn |
| Jun 30, 2024 | 2.41 Mn |
| Mar 31, 2024 | 6.54 Mn |
| Dec 31, 2023 | 2.31 Mn |
| Sep 30, 2023 | 1.23 Mn |
| Jun 30, 2023 | 1.23 Mn |
| Mar 31, 2023 | 2.21 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | 107.34 Mn |
| Jun 30, 2022 | 105.95 Mn |
| Mar 31, 2022 | 105.96 Mn |
| Dec 31, 2021 | 601,000.00 |
| Sep 30, 2021 | 624,878.00 |